| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657820 | Clinics and Research in Hepatology and Gastroenterology | 2016 | 6 Pages |
Abstract
These results indicate crucial roles played by fetuin A and selenoprotein P in the IR caused by HCV and that both hepatokines may be targets for the development of therapies to treat or inhibit insulin resistance associated to HCV. However, further studies on large scale should be conducted to confirm our findings.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Sahar A. Ali, Walaa M.H. Nassif, Dalia H.A. Abdelaziz,